Trial Profile
Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 31 Jan 2020
Price :
$35
*
At a glance
- Drugs Ganitumab (Primary)
- Indications Ewing's sarcoma
- Focus Expanded access; Therapeutic Use
- 26 Mar 2019 Status changed from recruiting to completed.
- 01 Feb 2017 New trial record